Results 81 to 90 of about 202,549 (253)
Autologous Transplantation for Older Adults with AML [PDF]
While the majority of patients with acute myeloid leukemia (AML) are above the age of 65 years at diagnosis, the outcome of older AML patients remains disappointing.
Pabst, Thomas +7 more
core +2 more sources
Investigation of Sintering Parameters for Low-Cost 3D-Printed Cast Iron Using Material Extrusion
Metal Material Extrusion (MEX/M) provides a rapid, low-cost additive manufacturing option for individual and batch productions; however, cast materials are not typically available in the material pool.
Matthew Drummond +3 more
doaj +1 more source
scTIGER2.0 is a deep‐learning framework that infers gene regulatory networks from single‐cell RNA sequencing data. By integrating correlation, pseudotime ordering, deep learning and bootstrap‐based significance testing, it reduces false positives and reveals directional gene interactions.
Nishi Gupta +3 more
wiley +1 more source
Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)-3
Copyright information:Taken from "Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)"http://www.biomedcentral.com/1471-2407/8/51BMC Cancer 2008;8():51-51.Published online 13 Feb 2008PMCID:PMC2258302.ed ...
Jean-Pierre Marie (60169) +8 more
core +1 more source
Optimization of the indications for allogeneic stem cell transplantation in Acute Myeloid Leukemia based on interactive diagnostic strategies [PDF]
The indications for allogeneic stem cell transplantation (SCT) in Acute Myeloid Leukemia (AML) represent a real challenge due to the clinical and genetic heterogeneity of the disorder.
Hartwig, Maite +5 more
core +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a potentially curative strategy for acute myeloid leukemia (AML), but the impact of HLA disparity in the era of posttransplant cyclophosphamide (PTCy) and reduced‐toxicity conditioning remains unclear. We performed an EBMT registry study including 275 adult AML patients in first
Daniele Avenoso +21 more
wiley +1 more source
ABSTRACT Mutations in FLT3 are present in approximately 30% of patients with AML. The addition of midostaurin (MIDO) to intensive chemotherapy (IC) became standard of care following the RATIFY trial, but comprehensive real‐world data spanning the full adult age spectrum and including both FLT3‐ITD and FLT3‐TKD mutations remain limited.
Mónica Alejandra Romero Riquelme +49 more
wiley +1 more source
ABSTRACT Posttransplant cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) improves outcomes in recipients of HLA mismatched unrelated donor (MMUD) allogeneic hematopoietic cell transplantation (allo HCT). Outcomes of MMUD HCT using PTCy in patients requiring reduced intensity or non‐myeloablative conditioning (RIC/NMA) are not well ...
Brian C. Shaffer +38 more
wiley +1 more source
Lture. The numbers of colonies and cell morphology were evaluated for each specimen. The probability of the AML specimen to respond to the peptide (increase of colony number, decrease of colony number and cell differentiation) was assessed.
Naomi Galili (86365) +2 more
core +1 more source
Clustering of settling microswimmers in turbulence [PDF]
Clustering of plankton plays a vital role in several biological activities, including feeding, predation, and mating. Gyrotaxis is one of the mechanisms that induces clustering.
J. Qiu +4 more
doaj +1 more source

